We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.CONFIDENTIAL TREATMENT REQUESTED EXECUTION VERSION NOVARTIS AG and GLAXOSMITHKLINE PLC and GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS LIMITED DEED OF AMENDMENT AND RESTATEMENT relating to the CONTRIBUTION AGREEMENT relating to the Consumer...Contribution Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020
CONFIDENTIAL TREATMENT REQUESTEDContribution Agreement • March 18th, 2016 • Glaxosmithkline PLC • Pharmaceutical preparations
Contract Type FiledMarch 18th, 2016 Company Industry
NOVARTIS AG and GLAXOSMITHKLINE PLC and GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS LIMITED DEED OF AMENDMENT AND RESTATEMENT relating to theContribution Agreement • January 27th, 2016 • Novartis Ag • Pharmaceutical preparations
Contract Type FiledJanuary 27th, 2016 Company Industry
CONFIDENTIAL TREATMENT REQUESTEDContribution Agreement • February 27th, 2015 • Glaxosmithkline PLC • Pharmaceutical preparations
Contract Type FiledFebruary 27th, 2015 Company IndustryAmended Novartis Disclosure Letter” means the Original Novartis Disclosure Letter, as amended and restated in the form set out in Schedule 3 to this Deed;
ContractContribution Agreement • January 27th, 2015 • Novartis Ag • Pharmaceutical preparations
Contract Type FiledJanuary 27th, 2015 Company IndustryConfidential portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission